Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice

Xiaoling Cheng, LingLing Fu, Jingyao Ma, Hao Gu, Zhenping Chen, Libo Zhao, Xiaoling Wang, Runhui Wu

Blood Adv (2021) 5 (19): 3799–3806.

https://doi.org/10.1182/bloodadvances.2020004110

Published: 2021

Journal Articles

Preclinical evaluation of immunotherapeutic regimens for fetal/neonatal alloimmune thrombocytopenia

Huiying Zhi, Maria T. Ahlen, Björn Skogen, Debra K. Newman, Peter J. Newman

Blood Adv (2021) 5 (18): 3552–3562.

https://doi.org/10.1182/bloodadvances.2021004371

Published: 2021

Includes: Supplemental data

Journal Articles

Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis

Blood Adv (2021) 5 (16): 3163–3173.

https://doi.org/10.1182/bloodadvances.2020003829

Published: 2021

Journal Articles

Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease

Alexis Leonard, Akshay Sharma, Naoya Uchida, David Stroncek, Sandhya R. Panch, Kamille West, Eoghan Molloy, Thomas E. Hughes, Sara Hauffe, Tiffani Taylor, Courtney Fitzhugh, Jane S. Hankins, Megan Wilson, Shengdar Q. Tsai, Mitchell J. Weiss, Matthew Hsieh, John F. Tisdale

Blood Adv (2021) 5 (9): 2403–2411.

https://doi.org/10.1182/bloodadvances.2021004232

Published: 2021

Includes: Supplemental data

Journal Articles

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Alexandra Schifferli, Andrea Heiri, Paul Imbach, Susanne Holzhauer, Markus G. Seidel, Diane Nugent, Marc Michel, Thomas Kühne

Blood Adv (2021) 5 (6): 1617–1626.

https://doi.org/10.1182/bloodadvances.2020003004

Published: 2021

Journal Articles

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

Tadeusz Robak, Maciej Kaźmierczak, Isidro Jarque, Vasile Musteata, Jacek Treliński, Nichola Cooper, Peter Kiessling, Ute Massow, Franz Woltering, Rose Snipes, Juan Ke, Grant Langdon, James B. Bussel, Stephen Jolles

Blood Adv (2020) 4 (17): 4136–4146.

https://doi.org/10.1182/bloodadvances.2020002003

Published: 2020

Includes: Supplemental data

Journal Articles

Phase 1/2a study of 177 Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Arne Kolstad, Tim Illidge, Nils Bolstad, Signe Spetalen, Ulf Madsbu, Caroline Stokke, Johan Blakkisrud, Ayca Løndalen, Noelle O'Rourke, Matthew Beasley, Wojciech Jurczak, Unn-Merete Fagerli, Michal Kaščák, Mike Bayne, Aleš Obr, Jostein Dahle, Lisa Rojkjaer, Veronique Pascal, Harald Holte

Blood Adv (2020) 4 (17): 4091–4101.

https://doi.org/10.1182/bloodadvances.2020002583

Published: 2020

Includes: Supplemental data

Journal Articles

Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantation

Baolin Tang, Lulu Huang, Huilan Liu, Siqi Cheng, Kaidi Song, Xuhan Zhang, Wen Yao, Lijuan Ning, Xiang Wan, Guangyu Sun, Yun Wu, Jiehui Cheng, Qi Long, Zimin Sun, Xiaoyu Zhu

Blood Adv (2020) 4 (16): 3829–3839.

https://doi.org/10.1182/bloodadvances.2020002257

Published: 2020

Includes: Supplemental data

Journal Articles

High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers

Hélène Guermouche, Noémie Ravalet, Nathalie Gallay, Caroline Deswarte, Amelie Foucault, Jenny Beaud, Emmanuelle Rault, Emeline Saindoy, Sébastien Lachot, Jean-Alain Martignoles, Valérie Gissot, Ludovic Suner, Emmanuel Gyan, François Delhommeau, Olivier Herault, Pierre Hirsch

Blood Adv (2020) 4 (15): 3550–3557.

https://doi.org/10.1182/bloodadvances.2020001582

Published: 2020

Includes: Supplemental data

Journal Articles

Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan

Takaaki Hato, Naoki Shimada, Yoshiyuki Kurata, Masataka Kuwana, Kingo Fujimura, Hirokazu Kashiwagi, Toshiro Takafuta, Mitsuru Murata, Yoshiaki Tomiyama

Blood Adv (2020) 4 (8): 1648–1655.

https://doi.org/10.1182/bloodadvances.2020001446

Published: 2020

Journal Articles

IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP

Manuel Carcao, Mariana Silva, Michele David, Robert J. Klaassen, MacGregor Steele, Victoria Price, Cindy Wakefield, Lussia Kim, Derek Stephens, Victor S. Blanchette

Blood Adv (2020) 4 (7): 1492–1500.

https://doi.org/10.1182/bloodadvances.2019001343

Published: 2020

Includes: Supplemental data

Journal Articles

A practical approach to evaluating postoperative thrombocytopenia

Leslie Skeith, Lisa Baumann Kreuziger, Mark A. Crowther, Theodore E. Warkentin

Blood Adv (2020) 4 (4): 776–783.

https://doi.org/10.1182/bloodadvances.2019001414

Published: 2020

Journal Articles

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Blood Adv (2019) 3 (22): 3780–3817.

https://doi.org/10.1182/bloodadvances.2019000812

Published: 2019

Includes: Supplemental data

Journal Articles

Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice

Toshiaki Shirai, Alexey S. Revenko, Justin Tibbitts, Anh T. P. Ngo, Annachiara Mitrugno, Laura D. Healy, Jennifer Johnson, Erik I. Tucker, Monica T. Hinds, Lisa M. Coussens, Owen J. T. McCarty, Brett P. Monia, András Gruber

Blood Adv (2019) 3 (20): 3080–3091.

https://doi.org/10.1182/bloodadvances.2019000250

Published: 2019

Includes: Supplemental data

Journal Articles

Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials

Yueh-Chwen Hsu, Tsung-Chih Chen, Chien-Chin Lin, Chang-Tsu Yuan, Chia-Lang Hsu, Hsin-An Hou, Chein-Jun Kao, Po-Han Chuang, Yu-Ren Chen, Wen-Chien Chou, Hwei-Fang Tien

Blood Adv (2019) 3 (15): 2355–2367.

https://doi.org/10.1182/bloodadvances.2019000391

Published: 2019

Includes: Supplemental data

Journal Articles

Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice

Cindy E. Neunert, Melissa J. Rose

Blood Adv (2019) 3 (12): 1907–1915.

https://doi.org/10.1182/bloodadvances.2019000279

Published: 2019

Journal Articles

Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing

Blood Adv (2019) 3 (11): 1702–1713.

https://doi.org/10.1182/bloodadvances.2019031948

Published: 2019

Includes: Supplemental data

Journal Articles

HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a–immunized women

Jens Kjeldsen-Kragh, Thomas L. Titze, Benedicte Alexandra Lie, John T. Vaage, Mette Kjær

Blood Adv (2019) 3 (7): 945–951.

https://doi.org/10.1182/bloodadvances.2019032227

Published: 2019

Journal Articles

Ontogeny of platelet function

Andreas Margraf, Claudia Nussbaum, Markus Sperandio

Blood Adv (2019) 3 (4): 692–703.

https://doi.org/10.1182/bloodadvances.2018024372

Published: 2019

Journal Articles

NPM1 mutated AML can relapse with wild-type NPM1 : persistent clonal hematopoiesis can drive relapse

Alexander Höllein, Manja Meggendorfer, Frank Dicker, Sabine Jeromin, Niroshan Nadarajah, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach

Blood Adv (2018) 2 (22): 3118–3125.

https://doi.org/10.1182/bloodadvances.2018023432

Published: 2018

NARROW

Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice

Preclinical evaluation of immunotherapeutic regimens for fetal/neonatal alloimmune thrombocytopenia

Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis

Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

Phase 1/2a study of 177 Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantation

High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers

Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan

IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP

A practical approach to evaluating postoperative thrombocytopenia

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice

Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials

Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice

Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing

HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a–immunized women

Ontogeny of platelet function

NPM1 mutated AML can relapse with wild-type NPM1 : persistent clonal hematopoiesis can drive relapse

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only